Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Benjamin Atchie

Diagnostic Radiology Englewood, CO Doctor of Osteopathy

NPI 1134402415 CMS profile 188449

499 E. Hampden Avenue, Suite 380, Englewood, CO 80113

Open in the dashboard

General payments

$35,270

387 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$43,869

2 holdings reported · through program year 2025

Research they led as principal investigator

$392,185 paid to institutions, not to them · program years 2019–2024

Through program year 2025, Benjamin Atchie of Englewood, CO is reported in the CMS Open Payments database as having received $35,270 across 387 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $392,185 in research payments, paid to institutions rather than to them. They also declared ownership or investment interests valued at $43,869 across 2 holdings.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 97th percentile of Diagnostic Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

9 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,083 72
2024 General $2,638 59
2023 General $10,137 42
2022 General $6,543 74
2021 General $1,188 35
2020 General $7,005 23
2019 General $4,674 82
2022 Ownership $24,237 1
2021 Ownership $19,632 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Benjamin Atchie
  • Diagnostic Radiology median
  • Middle half of Diagnostic Radiology
  • National median

In program year 2025, general payments to Benjamin Atchie were reported at $3,083. Among 8,325 Diagnostic Radiology profiles paid that year, the median was $112 and the middle half received between $32 and $349.

Show as a table
Year Benjamin Atchie Diagnostic Radiology median Middle half National median
2019 $4,674 $108 $29–$318 $163
2020 $7,005 $65 $21–$252 $114
2021 $1,188 $92 $24–$292 $132
2022 $6,543 $104 $29–$294 $149
2023 $10,137 $110 $29–$337 $160
2024 $2,638 $113 $30–$356 $164
2025 $3,083 $112 $32–$349 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Stryker Corporation $9,228 191 payments
  2. Medical Device Business Services, Inc. $8,000 3 payments
  3. Penumbra, Inc. $6,680 70 payments
  4. Siemens Medical Solutions USA, Inc. $6,575 8 payments
  5. Medtronic, Inc. $2,093 63 payments
  6. DePuy Synthes Sales Inc. $1,284 29 payments
  7. MicroVention, Inc. $967 15 payments
  8. Abbott Laboratories $143 1 payment
  9. Route 92 Medical, Inc. $102 1 payment
  10. Kaneka Pharma America LLC $65 1 payment
  11. Other $132 5 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $18,838 11 payments
  2. Food and Beverage $15,288 368 payments
  3. Travel and Lodging $1,144 8 payments
Products named General payments · program years 2019–2025
  1. EMBOTRAP $8,439 12 payments
  2. TRUFILL $8,285 7 payments
  3. CEREPAK UNIFORM $8,259 13 payments
  4. Pulsar Vascular PulseRider Aneurysm Neck Reconstruction Device $8,000 3 payments
  5. Penumbra System Neurointervention $3,417 34 payments
  6. Penumbra System Neurointervention $3,135 31 payments
  7. WINGSPAN $1,896 2 payments
  8. Pipeline $1,793 40 payments
  9. AXS VECTA 71 $1,485 10 payments
  10. SURPASS EVOLVE $1,374 18 payments
  11. Other $8,426 216 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

35

Median for Interventional Radiology: 38

Drug cost

$213

Median for Interventional Radiology: $333

Branded share of claims

100%

Median for Interventional Radiology: 53%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Clopidogrel Clopidogrel Bisulfate Brand 35 $213

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 554 Part D prescribers listed as Interventional Radiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 34 billing codes

Paid by Medicare

$77,102

Medicare's payments for the services billed

Medicare patients

86

Average age 76

Services billed

659

49 women, 37 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 45%
Atrial fibrillation 37%
Ischemic heart disease 33%
Diabetes 29%
Chronic kidney disease 29%
Depression 28%
COPD 21%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

387 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Diagnostic Radiology in Colorado

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record